Akinetic mutism and the story of David.

Neuropsychol Rehabil

c Speech and Language Therapy Department , Raphael Medical Centre, Kent , UK.

Published: March 2018

Following a description about the characteristics of akinetic mutism (AM) and how it differs from locked-in syndrome (LIS) and a disorder of consciousness (DOC), we present the case of David, a 71-year-old man with AM. David sustained a stroke following a middle cerebral artery (MCA) thrombus. A CT scan at the time detected old ischaemic infarcts affecting the right frontal lobe, the left occipital lobe and the left parietal lobe so David had bilateral brain damage. Initially thought to have a DOC, further neuropsychological assessments administered when David had improved a little, resulted in the diagnosis of AM. Although David spoke little, when he did speak, his words and phrases were well articulated, grammatical and with appropriate intonation. He was alert and visually aware and he was not paralysed. We discuss whether the diagnosis was correct and address the difficulties in assessing such patients.

Download full-text PDF

Source
http://dx.doi.org/10.1080/09602011.2017.1281147DOI Listing

Publication Analysis

Top Keywords

akinetic mutism
8
lobe left
8
david
6
mutism story
4
story david
4
david description
4
description characteristics
4
characteristics akinetic
4
mutism differs
4
differs locked-in
4

Similar Publications

A predictive model for cerebellar mutism syndrome based on lesion map in children with medulloblastoma.

Eur Radiol

December 2024

Department of Neurosurgery, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, China.

Background: This study aimed to establish a voxel-based map to predict the occurrence of cerebellar mutism syndrome (CMS) and investigate the relationship between CMS and motor dysfunction.

Method: This multicenter study cohort included 224 patients diagnosed with medulloblastoma at Beijing Children's Hospital (n = 88) and Beijing Tiantan Hospital (n = 136). The dataset was randomly divided into training (n = 95), test (n = 41), and validation (n = 88) datasets.

View Article and Find Full Text PDF
Article Synopsis
  • - Creutzfeldt-Jakob disease (CJD) is a rare and fatal brain disorder that typically affects people in their 60s and manifests as rapid cognitive decline due to the accumulation of abnormal prion proteins, leading to death within a year of diagnosis.
  • - Diagnosis of CJD is complicated by overlapping symptoms with other degenerative and infectious diseases, requiring a comprehensive approach that includes clinical evaluations and advanced imaging techniques.
  • - A case study of a 60-year-old man with probable sporadic CJD highlights symptoms such as dementia and rigidity, as well as MRI findings that indicate severe neurodegeneration, demonstrating the need for early identification for palliative care, since there is no effective treatment.
View Article and Find Full Text PDF

Intermittent clinical course of akinetic mutism is very unusual. We describe a 74-year-old man who started to demonstrate episodes of altered mental state with stopped moving and talking, poor response to commands, and muscle stiffness in both upper limbs approximately 1.5 months after cardioembolic bilateral paramedian thalamic infarction.

View Article and Find Full Text PDF

Description Of The Cases: A series of 6 cases with a probable diagnosis of sporadic CJD, treated in a Peruvian national reference hospital, are presented.

Clinical Findings: The relevant clinical signs were rapidly progressive dementia and myoclonus, followed by akinetic mutism and pyramidal signs.

Treatment And Results: Of the cases presented, 80% were men, with an average age of presentation of 65 years and duration from diagnosis to death of 6.

View Article and Find Full Text PDF

Introduction: The C9orf72 mutation can manifest in diverse clinical ways, including rapid cognitive decline, parkinsonism, or late-life neuropsychiatric symptoms, sometimes mimicking autoimmune encephalitis.

Case Report: A 64-year-old female presented to the autoimmune neurology clinic with rapidly progressive dementia (RPD) associated with episodes of headache, confusion, auditory hallucinations, and abnormal electroencephalogram. She was treated empirically at an outside hospital for possible autoimmune encephalitis with intravenous methylprednisolone, but there was no improvement, and rapid cognitive decline continued.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!